Drug repositioning by kernel-based integration of molecular structure, molecular activity, and phenotype data.
Computational inference of novel therapeutic values for existing drugs, i.e., drug repositioning, offers the great prospect for faster and low-risk drug development. Previous researches have indicated that chemical structures, target proteins, and side-effects could provide rich information in drug...
Main Authors: | Yongcui Wang, Shilong Chen, Naiyang Deng, Yong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3823875?pdf=render |
Similar Items
-
Correction: Drug Repositioning by Kernel-Based Integration of Molecular Structure, Molecular Activity, and Phenotype Data
by: Yongcui Wang, et al.
Published: (2013-01-01) -
Correction: Drug Repositioning by Kernel-Based Integration of Molecular Structure, Molecular Activity, and Phenotype Data.
by: Yongcui Wang, et al.
Published: (2013-01-01) -
The Clinical and Molecular Characterization of Gastric Cancer Patients in Qinghai-Tibetan Plateau
by: Guanghong Rong, et al.
Published: (2020-06-01) -
Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes
by: Raúl A. Mejía-Pedroza, et al.
Published: (2018-08-01) -
Computational Prediction of Drug Responses in Cancer Cell Lines From Cancer Omics and Detection of Drug Effectiveness Related Methylation Sites
by: Rui Yuan, et al.
Published: (2020-08-01)